Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia
Abstract Background Off-patent pharmaceuticals (OPPs) hold vital importance in meeting public health objectives, especially in developing countries where resources are limited. OPPs are comprised of off-patent originals, branded generics and unbranded generics; nonetheless, these products are not id...
Saved in:
Main Authors: | Andras Inotai (Author), Diana Brixner (Author), Nikos Maniadakis (Author), Iwan Dwiprahasto (Author), Erna Kristin (Author), Agus Prabowo (Author), Alfi Yasmina (Author), Sigit Priohutomo (Author), Bertalan Németh (Author), Kalman Wijaya (Author), Zoltan Kalo (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand
by: Anke-Peggy Holtorf, et al.
Published: (2021) -
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
by: Baher Elezbawy, et al.
Published: (2022) -
Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
by: Julia I. Drake, et al.
Published: (2017) -
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
by: Panos Kanavos, et al.
Published: (2015) -
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
by: Ivett Jakab, et al.
Published: (2020)